Pluristem to Present Scientific Poster and Corporate Overview at Stem Cell … – Wall Street Journal
|
Pluristem to Present Scientific Poster and Corporate Overview at Stem Cell …
Wall Street Journal HAIFA, Israel, Oct. 15, 2013 (GLOBE NEWSWIRE) — Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today that the company will be actively participating in the Stem Cell Meeting on … |
